P21WAF1 control of epithelial cell cycle and cell fate

Critical Reviews in Oral Biology and Medicine

Volumn 13, Issue 6, 2002, Pages 453-464

  Weinberg, Wendy C ^a,c   Denning, Mitchell F ^b  

^a Division of Viral Products   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Cell cycle; Cyclin dependent kinase, cell transformation; Keratinocytes; P21WAF1

Indexed keywords

CYCLIN DEPENDENT KINASE; PROTEIN P21; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; ENZYME INHIBITOR; MUTAGENIC AGENT;

APOPTOSIS; CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CELL FATE; CELL TRANSFORMATION; EPITHELIUM CELL; GENE CONTROL; KERATINOCYTE; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; CELL DIVISION; CYTOLOGY; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MOUTH MUCOSA; NEOPLASM; PATHOLOGY; PHYSIOLOGY; SKIN;

APOPTOSIS; CELL CYCLE; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; ENZYME INHIBITORS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; MOUTH MUCOSA; MUTAGENS; NEOPLASMS; SKIN;

EID: 0036371158     PISSN: 10454411     EISSN: None     Source Type: Journal    
DOI: 10.1177/154411130201300603     Document Type: Review

References (143)

1. WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model. Oncogene 19:5338-5347.
2. Alani RM, Hasskarl J, Munger K (1998). Alterations in cyclindependent kinase 2 function during differentiation of primary human keratinocytes. Mol Carcinog 23:226-233.
3. WAF1/CIP1/SDI1 is elevated through a p53-independent pathway by mimosine. Cell Growth Differ 7:893-901.
4. Attardi LD, Lowe SW, Brugarolas J, Jacks T (1996). Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J 15:3693-3701.
5. WAF1. Curr Biol 7:71-80.
6. Blagosklonny MV, Pardee AB (2001). Exploiting cancer cell cycling for selective protection of normal cells. Cancer Res 61:4301-4305.
7. Blagosklonny MV, Wu GS, Omura S, El Deiry WS (1996). Proteasome-dependent regulation of p21WAF1/CIP1 expression. Biochem Biophys Res Commun 227:564-569.
8. WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth. Cancer Res 57:1442-1446.
9. Brissette JL, Missero C, Yuspa SH, Dotto GP (1993). Different levels of v-Ha-ras p21 expression in primary keratinocytes transformed with Harvey sarcoma virus correlate with benign versus malignant behavior. Mol Carcinog 7:21-25.
10. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ (1995). Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377:552-557.
11. Brugarolas J, Moberg K, Boyd SD, Taya Y, Jacks T, Lees JA (1999). Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation. Proc Natl Acad Sci USA 96:1002-1007.
12. Cardinali M, Jakus J, Shah S, Ensley JF, Robbins KC, Yeudall WA (1998). p21(WAF1/Cip1) retards the growth of human squamous cell carcinomas in vivo. Oral Oncol 34:211-218.
13. Cayrol C, Ducommun B (1998). Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21. Oncogene 17:2437-2444.
14. Chang BD, Xuan Y, Broude EV, Zhu H, Schott B, Fang J, et al. (1999). Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene 18:4808-4818.
15. Chang BD, Broude EV, Fang J, Kalinichenko TV, Abdryashitov R, Poole JC, et al. (2000a). p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells. Oncogene 19:2165-2170.
16. Chang BD, Watanabe K, Broude EV, Fang J, Poole JC, Kalinichenko TV, et al. (2000b). Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc Natl Acad Sci USA 97:4291-4296.
17. Chen J, Jackson PK, Kirschner MW, Dutta A (1995). Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 374:386-388.
18. Chen J, Willingham T, Shuford M, Bruce D, Rushing E, Smith Y, et al. (1996). Effects of ectopic overexpression of p21(WAF1/CIP1) on aneuploidy and the malignant phenotype of human brain tumor cells. Oncogene 13:1395-1403.
19. Cheng C, Tennenbaum T, Dempsey PJ, Coffey RJ, Yuspa SH, Dlugosz AA (1993). Epidermal growth factor receptor ligands regulate keratin 8 expression in keratinocytes, and transforming growth factor alpha mediates the induction of keratin 8 by the v-rasHa oncogene. Cell Growth Differ 4:317-327.
20. Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM, et al. (1999). The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 18:1571-1583.
21. WAF1. Science 277:1996-2000.
22. Corroyer S, Nabeyrat E, Clement A (1997). Involvement of the cell cycle inhibitor CIP1/WAF1 in lung alveolar epithelial cell growth arrest induced by glucocorticoids. Endocrinology 138:3677-3685.
23. Courtois SJ, Woodworth CD, Degreef H, Garmyn M (1997). Early ultraviolet B-induced G1 arrest and suppression of the malignant phenotype by wild-type p53 in human squamous cell carcinoma cells. Exp Cell Res 233:135-144.
24. Cox LS (1997). Multiple pathways control cell growth and transformation: overlapping and independent activities of p53 and p21Cip1/WAF1/Sdi1. J Pathol 183:134-140.
25. Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF (1995a). Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 92:5545-5549.
26. Datto MB, Yu Y, Wang XF (1995b). Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter. J Biol Chem 270:28623-28628.
27. Decesse JT, Medjkane S, Datto MB, Cremisi CE (2001). RB regulates transcription of the p21/WAF1/CIP1 gene. Oncogene 20:962-971.
28. Delavaine L, La Thangue NB (1999). Control of E2F activity by p21Waf1/Cip1. Oncogene 18:5381-5392.
29. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P (1995). Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684.
30. WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control. Science 280:1069-1072.
31. Dickson MA, Hahn WC, Ino Y, Ronfard V, Wu JY, Weinberg RA, et al. (2000). Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 20:1436-1447.
32. Dlugosz AA, Glick AB, Tennenbaum T, Weinberg WC, Yuspa SH (1995). Isolation and utilization of epidermal keratinocytes for oncogene research. Meth Enzymol 254:3-20.
33. Eastham JA, Hall SJ, Sehgal I, Wang J, Timme TL, Yang G, et al. (1995). In vivo gene therapy with p53 or p21 adenovirus for prostate cancer. Cancer Res 55:5151-5155.
34. El Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
35. El Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, et al. (1994). WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54:1169-1174.
36. WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res 55:2910-2919.
37. Enders GH, Koh J, Missero C, Rustgi AK, Harlow E (1996). p16 inhibition of transformed and primary squamous epithelial cells. Oncogene 12:1239-1245.
38. Erber R, Klein W, Andl T, Enders C, Born AI, Conradt C, et al. (1997). Aberrant p21(CIP1/WAF1) protein accumulation in head-and-neck cancer. Int J Cancer 74:383-389.
39. Fan Z, Lu Y, Wu X, DeBlasio A, Koff A, Mendelsohn J (1995). Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition. J Cell Biol 131:235-242.
40. Franklin DS, Godfrey VL, O'Brien DA, Deng C, Xiong Y (2000). Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol Cell Biol 20:6147-6158.
41. Fuchs E, Byrne C (1994). The epidermis: rising to the surface. Curr Opin Genet Dev 4:725-736.
42. Gartel AL, Tyner AL (1999). Transcriptional regulation of the p21((WAF1/CIP1)) gene. Exp Cell Res 246:280-289.
43. Gartel AL, Ye X, Goufman E, Shianov P, Hay N, Najmabadi F, et al. (2001). Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3. Proc Natl Acad Sci USA 98:4510-4515.
44. Goubin F, Ducommun B (1995). Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor. Oncogene 10:2281-2287.
45. Green H (1977). Terminal differentiation of cultured human epidermal cells. Cell 11:405-416.
46. Greenhalgh DA, Wang XJ, Donehower LA, Roop DR (1996a). Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha. Cancer Res 56:4413-4423.
47. Greenhalgh DA, Wang XJ, Roop DR (1996b). Multistage epidermal carcinogenesis in transgenic mice: cooperativity and paradox. J Investig Dermatol Symp Proc 1:162-176.
48. Gu Y, Turck CW, Morgan DO (1993). Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366:707-710.
49. Haapajarvi T, Kivinen L, Heiskanen A, des BC, Datto MB, Wang XF, et al. (1999). UV radiation is a transcriptional inducer of p21(Cip1/Waf1) cyclin-kinase inhibitor in a p53-independent manner. Exp Cell Res 248:272-279.
50. Hainaut P, Hernandez T, Robinson A, Rodriguez-Tome P, Flores T, Hollstein M, et al. (1998). IARC database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Res 26:205-213.
51. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, et al. (1995). Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018-1021.
52. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
53. Harvat BL, Jetten AM (2001). Decreased growth inhibitory responses of squamous carcinoma cells to interferon-gamma involve failure to recruit cki proteins into cdk2 complexes. J Invest Dermatol 117:1274-1281.
54. Harvat BL, Wang A, Seth P, Jetten AM (1998). Up-regulation of p27Kip1, p21WAF1/Cip1 and p16Ink4a is associated with, but not sufficient for, induction of squamous differentiation. J Cell Sci 111:1185-1196.
55. Hauser PJ, Agrawal D, Flanagan M, Pledger WJ (1997). The role of p27kip1 in the in vitro differentiation of murine keratinocytes. Cell Growth Differ 8:203-211.
56. Hennings H, Michael D, Cheng C, Steinert P, Holbrook K, Yuspa SH (1980). Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 19:245-254.
57. Hennings H, Shores R, Mitchell P, Spangler EF, Yuspa SH (1985). Induction of papillomas with a high probability of conversion to malignancy. Carcinogenesis 6:1607-1610.
58. Herzinger T, Funk JO, Hillmer K, Eick D, Wolf DA, Kind P (1995). Ultraviolet B irradiation-induced G2 cell cycle arrest in human keratinocytes by inhibitory phosphorylation of the cdc2 cell cycle kinase. Oncogene 11:2151-2156.
59. Hu PP, Shen X, Huang D, Liu Y, Counter C, Wang XF (1999). The MEK pathway is required for stimulation of p21(WAF1/CIP1) by transforming growth factor-beta. J Biol Chem 274:35381-35387.
60. Jakus J, Yeudall WA (1996). Growth inhibitory concentrations of EGF induce p21 (WAF1/Cip1) and alter cell cycle control in squamous carcinoma cells. Oncogene 12:2369-2376.
61. Jiang H, Lin J, Su ZZ, Herlyn M, Kerbel RS, Weissman BE, et al. (1995). The melanoma differentiation-associated gene mda-6, which encodes the cyclin -dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. Oncogene 10:1855-1864.
62. Kitaura H, Shinshi M, Uchikoshi Y, Ono T, Iguchi-Ariga SM, Ariga H (2000). Reciprocal regulation via protein-protein interaction between c-Myc and p21(cip1/waf1/sdi1) in DNA replication and transcription. J Biol Chem 275:10477-10483.
63. Koutsodontis G, Tentes I, Papakosta P, Moustakas A, Kardassis D (2001). Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein. J Biol Chem 276:29116-29125.
64. WAF1/CIP1/SDI1, changes in the expression of p21-regulated genes, and a senescence-like phenotype. Cancer Res 61:7754-7762.
65. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, et al. (1997). New functional activities for the p21 family of CDK inhibitors. Genes Dev 11:847-862.
66. WAF1 and G1 cellcycle arrest by the chemopreventive agent apigenin. Mol Carcinog 19:74-82.
67. Li CY, Suardet L, Little JB (1995). Potential role of WAF1/Cip1/p21 as a mediator of TGF-beta cytoinhibitory effect. J Biol Chem 270:4971-4974.
68. Li R, Hannon GJ, Beach D, Stillman B (1996). Subcellular distribution of p21 and PCNA in normal and repair-deficient cells following DNA damage. Curr Biol 6:189-199.
69. Li Y, Dowbenko D, Lasky LA (2002). AKT/PKB phosphorylation of p21Cip1/WAF1 enhances protein stability of p21Cip1/WAF1 and promotes cell survival. J Biol Chem 27:11352-11361.
70. Lin J, Reichner C, Wu X, Levine AJ (1996). Analysis of wild-type and mutant p21WAF-1 gene activities. Mol Cell Biol 16:1786-1793.
71. Liu M, Iavarone A, Freedman LP (1996). Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J Biol Chem 271:31723-31728.
72. WAF1/CIP1 protein in keratinocytes without p53. J Invest Dermatol 113:283-284.
73. WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway. Cancer Res 56:31-35.
74. Loughran O, Malliri A, Owens D, Gallimore PH, Stanley MA, Ozanne B, et al. (1996). Association of CDKN2A/p16INK4A with human head and neck keratinocyte replicative senescence: relationship of dysfunction to immortality and neoplasia. Oncogene 13:561-568.
75. Luo Y, Hurwitz J, Massagué J (1995). Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature 375:159-161.
76. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, et al. (1995). p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 9:935-944.
77. Martin-Caballero J, Flores JM, Garcia-Palencia P, Serrano M (2001). Tumor susceptibility of p21(Waf1/Cip1)-deficient mice. Cancer Res 61:6234-6238.
78. Martinez LA, Chen Y, Fischer SM, Conti CJ (1999). Coordinated changes in cell cycle machinery occur during keratinocyte terminal differentiation. Oncogene 18:397-406.
79. McConnell BB, Starborg M, Brookes S, Peters G (1998). Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr Biol 8:351-354.
80. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D (1994). Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54:3391-3395.
81. Missero C, Calautti E, Eckner R, Chin J, Tsai LH, Livingston DM, et al. (1995). Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci USA 92:5451-5455.
82. Missero C, Di Cunto F, Kiyokawa H, Koff A, Dotto GP (1996). The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes Dev 10:3065-3075.
83. WAF1/CIP1 expression and induces S-phase entry in 12-Otetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells. Cell Growth Differ 10:223-230.
84. Munro J, Stott FJ, Vousden KH, Peters G, Parkinson EK (1999). Role of the alternative INK4A proteins in human keratinocyte senescence: evidence for the specific inactivation of p16INK4A upon immortalization. Cancer Res 59:2516-2521.
85. Mutoh M, Lung FD, Long YQ, Roller PP, Sikorski RS, O'Connor PM (1999). A p21(Waf1/Cip1)carboxyl-terminal peptide exhibited cyclin-dependent kinase-inhibitory activity and cytotoxicity when introduced into human cells. Cancer Res 59:3480-3488.
86. Nakanishi M, Robetorye RS, Pereira-Smith OM, Smith JR (1995). The C-terminal region of p21SDI1/WAF1/CIP1 is involved in proliferating cell nuclear antigen binding but does not appear to be required for growth inhibition. J Biol Chem 270:17060-17063.
87. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR (1994). Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211:90-98.
88. Paramio JM, Segrelles C, Ruiz S, Martin-Caballero J, Page A, Martinez J, et al. (2001). The ink4a/arf tumor suppressors cooperate with p21cip1/waf in the processes of mouse epidermal differentiation, senescence, and carcinogenesis. J Biol Chem 276:44203-44211.
89. Park JW, Jang MA, Lee YH, Passaniti A, Kwon TK (2001). p53-independent elevation of p21 expression by PMA results from PKC-mediated mRNA stabilization. Biochem Biophys Res Commun 280:244-248.
90. Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, et al. (1995). p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 267:1024-1027.
91. Perkins ND, Felzien LK, Betts JC, Leung K, Beach DH, Nabel GJ (1997). Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science 275:523-527.
92. Philipp J, Vo K, Gurley KE, Seidel K, Kemp CJ (1999). Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis. Oncogene 18:4689-4698.
93. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massagué J, Roberts JM, et al. (1994a). p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 8:9-22.
94. Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, et al. (1994b). Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66.
95. Ponten F, Berne B, Ren ZP, Nister M, Ponten J (1995). Ultraviolet light induces expression of p53 and p21 in human skin: effect of sunscreen and constitutive p21 expression in skin appendages. J Invest Dermatol 105:402-406.
96. Poon RY, Hunter T (1998). Expression of a novel form of p21Cip1/Waf1 in UV-irradiated and transformed cells. Oncogene 16:1333-1343.
97. Prowse DM, Bolgan L, Molnar A, Dotto GP (1997). Involvement of the Sp3 transcription factor in induction of p21Cip1/WAF1 in keratinocyte differentiation. J Biol Chem 272:1308-1314.
98. Rangarajan A, Talora C, Okuyama R, Nicolas M, Mammucari C, Oh H, et al. (2001). Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J 20:3427-3436.
99. Rheinwald JG, Beckett MA (1980). Defective terminal differentiation in culture as a consistent and selectable character of malignant human keratinocytes. Cell 22:629-632.
100. Rossig L, Jadidi AS, Urbich C, Badorff C, Zeiher AM, Dimmeler S (2001). Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells. Mol Cell Biol 21:5644-5657.
101. Rossig L, Badorff C, Holzmann Y, Zeiher AM, Dimmeler S (2002). Glycogen synthase kinase-3 couples Akt-dependent signaling to the regulation of p21(Cip1) degradation. J Biol Chem 277:9684-9689.
102. Rousseau D, Cannella D, Boulaire J, Fitzgerald P, Fotedar A, Fotedar R (1999). Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway. Oncogene 18:4313-4325.
103. Russo T, Zambrano N, Esposito F, Ammendola R, Cimino F, Fiscella M, et al. (1995). A p53-independent pathway for activation of WAF1/CIP1 expression following oxidative stress. J Biol Chem 270:29386-29391.
104. Seitz CS, Lin Q, Deng H, Khavari PA (1998). Alterations in NFkappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB. Proc Natl Acad Sci USA 95:2307-2312.
105. Seitz CS, Deng H, Hinata K, Lin Q, Khavari PA (2000). Nuclear factor kappaB subunits induce epithelial cell growth arrest. Cancer Res 60:4085-4092.
106. Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA (1996). Role of the INK4a locus in tumor suppression and cell mortality. Cell 85:27-37.
107. Sharpless NE, DePinho RA (1999). The INK4A/ARF locus and its two gene products. Curr Opin Genet Dev 9:22-30.
108. Sheaff RJ, Singer JD, Swanger J, Smitherman M, Roberts JM, Clurman BE (2000). Proteasomal turnover of p21cip1 does not require p21cipI ubiquitination. Mol Cell 5:403-410.
109. Sherr CJ, Roberts JM (1995). Inhibitors of mammalian G1 cyclindependent kinases. Genes Dev 9:1149-1163.
110. Sherr CJ, Roberts JM (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512.
111. Shim J, Lee H, Park J, Kim H, Choi EJ (1996). A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature 381:804-806.
112. Shiohara M, El Deiry WS, Wada M, Nakamaki T, Takeuchi S, Yang R, et al. (1994). Absence of WAF1 mutations in a variety of human malignancies. Blood 84:3781-3784.
113. Stein GH, Dulic V (1998). Molecular mechanisms for the senescent cell cycle arrest. J Invest Dermatol Symp Proc 3:14-18.
114. Strickland JE, Greenhalgh DA, Koceva-Chyla A, Hennings H, Restrepo C, Balaschak M, et al. (1988). Development of murine epidermal cell lines which contain an activated rasHa oncogene and form papillomas in skin grafts on athymic nude mouse hosts. Cancer Res 48:165-169.
115. WAF1 and IAP gene family ILP. Oncogene 17:931-939.
116. Suzuki A, Tsutomi Y, Miura M, Akahane K (1999). Caspase 3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21. Oncogene 18:1239-1244.
117. Suzuki A, Kawano H, Hayashida M, Hayasaki Y, Tsutomi Y, Akahane K (2000). Procaspase 3/p21 complex formation to resist fas-mediated cell death is initiated as a result of the phosphorylation of p21 by protein kinase A. Cell Death Differ 7:721-728.
118. Symington BE, Carter WG (1995). Modulation of epidermal differentiation by epiligrin and integrin alpha 3 beta 1. J Cell Sci 108(Pt 2):831-838.
119. WAF1 by phorbol ester and calcium in human keratinocytes through a protein kinase C-dependent pathway. Am J Pathol 153:39-45.
120. Topley GI, Okuyama R, Gonzales JG, Conti C, Dotto GP (1999). p21(WAF1/Cip1) functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential. Proc Natl Acad Sci USA 96:9089-9094.
121. Toyoshima H, Hunter T (1994). p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67-74.
122. Tron VA, Tang L, Yong WP, Trotter MJ (1996). Differentiation-associated overexpression of the cyclin-dependent kinase inhibitor p21waf-1 in human cutaneous squamous cell carcinoma. Am J Pathol 149:1139-1146.
123. van Oijen MG, Tilanus MG, Medema RH, Slootweg PJ (1998). Expression of p21 (Waf1/Cip1) in head and neck cancer in relation to proliferation, differentiation, p53 status and D1 expression. J Oral Pathol Med 27:367-375.
124. Waga S, Hannon GJ, Beach D, Stillman B (1994). The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574-578.
125. Wan X, Kong J, Li YC (2001). Protein kinase C is involved in the regulation of hairless mRNA expression during mouse keratinocyte differentiation. Biochem Biophys Res Commun 294:99-105.
126. Wang YA, Elson A, Leder P (1997). Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice. Proc Natl Acad Sci USA 94:14590-14595.
127. Ha oncogene. Cancer Res 54:5584-5592.
128. Weinberg WC, Azzoli CG, Chapman K, Levine AJ, Yuspa SH (1995). p53-mediated transcriptional activity increases in differentiating epidermal keratinocytes in association with decreased p53 protein. Oncogene 10:2271-2279.
129. Weinberg WC, Montano NE, Deng C (1997). Loss of p21CIP1/WAF1 does not recapitulate accelerated malignant conversion caused by p53 loss in experimental skin carcinogenesis. Oncogene 15:685-690.
130. WAF1 enhances papilloma formation but not malignant conversion in experimental mouse skin carcinogenesis. Cancer Res 59:2050-2054.
131. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D (1993a). p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704.
132. Xiong Y, Zhang H, Beach D (1993b). Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev 7:1572-1583.
133. Yang WC, Mathew J, Velcich A, Edelmann W, Kucherlapati R, Lipkin M, et al. (2001). Targeted inactivation of the p21(WAF1/cip1) gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosal. Cancer Res 61:565-569.
134. Yang WL, Zeng YX, El Deiry WS, Nason-Burchenal K, Dmitrovsky E, Chin KV (1999). Transcriptional activation of the cyclindependent kinase inhibitor p21 by PML/RARalpha. Mol Cell Biol Res Commun 1:125-131.
135. WAF1/CIP1 is unrelated to p53 tumour suppressor gene status in oral squamous cell carcinomas. Oral Oncol 34:198-203.
136. Yuspa SH (1994). The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis - thirty-third G.H.A. Clowes Memorial Award Lecture. Cancer Res 54:1178-1189.
137. Yuspa SH, Kilkenny AE, Steinert PM, Roop DR (1989). Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in vitro. J Cell Biol 109:1207-1217.
138. Zakut R, Givol D (1995). The tumor suppression function of p21Waf is contained in its N-terminal half ('half-WAF'). Oncogene 11:393-395.
139. WAF1/CIP1 expression by p53-independent pathways. Oncogene 12:1557-1564.
140. Zhang P, Wong C, Liu D, Finegold M, Harper JW, Elledge SJ (1999). p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step. Genes Dev 13:213-224.
141. Zhang Y, Fujita N, Tsuruo T (1999). Caspase-mediated cleavage of p21Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene 18:1131-1138.
142. Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC (2001). Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylafion in HER-2/neu-overexpressing cells. Nat Cell Biol 3:245-252.
143. Zhu AJ, Watt FM (1996). Expression of a dominant negative cadherin mutant inhibits proliferation and stimulates terminal differentiation of human epidermal keratinocytes. J Cell Sci 109(Pt 13):3013-3023.